全球内分泌检测市场规模、份额、趋势和成长分析报告（2026-2034年）

预计内分泌检测市场将从 2025 年的 38.9 亿美元成长到 2034 年的 80.1 亿美元，2026 年至 2034 年的复合年增长率为 8.36%。

由于糖尿病、甲状腺功能障碍和肾上腺功能不全等荷尔蒙相关疾病的盛行率不断上升，全球内分泌检测市场正稳定成长。人们对疾病早期检测和预防医学的日益重视，推动了定期内分泌检测的普及。人口老化和文明病相关的健康问题也促使全球对诊断检测服务的需求不断增长。

关键成长要素包括免疫检测和自动化诊断分析仪技术的进步，这些技术能够提供准确快速的检测结果。新兴市场对就地检验解决方案的日益普及以及检查室基础设施的改善，进一步推动了市场成长。此外，医疗保健支出的成长以及政府针对慢性病管理的政策也为市场发展提供了支持。

未来前景一片光明，主要得益于个人化医疗的日益普及和荷尔蒙疗法的拓展。数位健康平台与人工智慧诊断技术的融合有望提升检测的准确性和效率。加大对研发和诊断技术创新的投入预计将推动该领域取得进一步进展。随着人们对内分泌健康意识的不断提高，全球市场预计将持续成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球内分泌检测市场：依检测类型划分

• 市场分析、洞察与预测
• 人类绒毛膜促性腺激素分泌(HCG) 荷尔蒙检测
• 甲状腺刺激素（TSH）检测
• 胰岛素测试
• 孕酮测试
• 黄体激素(LH) 检测
• 催乳素试验
• 其他测试类型

第五章 全球内分泌检测市场：依技术划分

• 市场分析、洞察与预测
• 免疫检测
• 质谱分析
• 层析法
• 基于核酸的
• 其他技术

第六章：全球内分泌检测市场：依最终用途划分

• 市场分析、洞察与预测
• 临床检查室
• 医院
• 诊断中心
• 其他最终用户

第七章 全球内分泌检测市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott
  • Agilent
  • Beckman Coulter
  • Bio RAD
  • Biomedical Technologies
  • Biomerieux
  • DH Tech
  • Diasorin
  • Labcorp
  • Quidelortho
  • Qiagen
  • Quest Diagnostics
  • Roche

The Endocrine Testing Market size is expected to reach USD 8.01 Billion in 2034 from USD 3.89 Billion (2025) growing at a CAGR of 8.36% during 2026-2034.

The Global Endocrine Testing Market is growing steadily due to the rising prevalence of hormonal disorders such as diabetes, thyroid dysfunction, and adrenal imbalances. Increasing awareness about early disease detection and preventive healthcare is encouraging routine endocrine assessments. Expanding geriatric populations and lifestyle-related health conditions are also contributing to greater demand for diagnostic testing services worldwide.

Major growth drivers include technological advancements in immunoassays and automated diagnostic analyzers that provide accurate and rapid results. Growing adoption of point-of-care testing solutions and improved laboratory infrastructure in emerging markets are further fueling expansion. Additionally, rising healthcare expenditure and government initiatives focused on chronic disease management are supporting market development.

Future prospects appear promising as personalized medicine gains traction and hormone-based therapies expand. Integration of digital health platforms and AI-powered diagnostics may enhance test accuracy and efficiency. Increasing investments in research and diagnostic innovation are expected to drive further advancements. As awareness about endocrine health continues to rise, sustained market growth is anticipated globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Type

• Human Chorionic Gonadotropin (HCG) Hormone Test
• Thyroid Stimulating Hormone (TSH) Test
• Insulin Test
• Progesterone Test
• Luteinizing Hormone (LH) Test
• Prolactin Test
• Other Test Types

By Technology

• Immunoassay
• Mass Spectroscopy
• Chromatography
• Nucleic Acid Based
• Other Technologies

By End Use

• Clinical Laboratories
• Hospitals
• Diagnostic Centers
• Other End Users

COMPANIES PROFILED

• Abbott, Agilent, Beckman Coulter, Bio RAD, Biomedical Technologies, Biomerieux, DH Tech, Diasorin, Labcorp, Quidelortho, Qiagen, Quest Diagnostics, Roche
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ENDOCRINE TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Test Type
• 4.2. Human Chorionic Gonadotropin (HCG) Hormone Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Thyroid Stimulating Hormone (TSH) Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Insulin Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Progesterone Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Luteinizing Hormone (LH) Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Prolactin Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Other Test Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ENDOCRINE TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Mass Spectroscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nucleic Acid Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ENDOCRINE TESTING MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Clinical Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ENDOCRINE TESTING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Test Type
  • 7.2.2 By Technology
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Test Type
  • 7.3.2 By Technology
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Test Type
  • 7.4.2 By Technology
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Test Type
  • 7.5.2 By Technology
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Test Type
  • 7.6.2 By Technology
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ENDOCRINE TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott
  • 9.2.2 Agilent
  • 9.2.3 Beckman Coulter
  • 9.2.4 Bio RAD
  • 9.2.5 Biomedical Technologies
  • 9.2.6 Biomerieux
  • 9.2.7 DH Tech
  • 9.2.8 Diasorin
  • 9.2.9 Labcorp
  • 9.2.10 Quidelortho
  • 9.2.11 Qiagen
  • 9.2.12 Quest Diagnostics
  • 9.2.13 Roche